These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 2445722)

  • 21. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Melino MR; Sigal NH
    J Immunol; 1990 Jan; 144(1):251-8. PubMed ID: 1688572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicochemical properties of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis.
    Tanaka H; Kuroda A; Marusawa H; Hashimoto M; Hatanaka H; Kino T; Goto T; Okuhara M
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):11-6. PubMed ID: 2445067
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of mixed lymphocyte reaction to identify subimmunosuppressive FK-506 levels in mice.
    Ellis RA; Brenner MJ; Mackinnon SE; Myckatyn TM; Hunter DA
    Microsurgery; 2003; 23(3):276-82. PubMed ID: 12833332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FR-900520 and FR-900523, novel immunosuppressants isolated from a Streptomyces. II. Fermentation, isolation and physico-chemical and biological characteristics.
    Hatanaka H; Kino T; Miyata S; Inamura N; Kuroda A; Goto T; Tanaka H; Okuhara M
    J Antibiot (Tokyo); 1988 Nov; 41(11):1592-601. PubMed ID: 2461926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.
    Kay JE; Benzie CR; Goodier MR; Wick CJ; Doe SE
    Immunology; 1989 Aug; 67(4):473-7. PubMed ID: 2475433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BTS 71 412: in vitro profile of a novel pyrazolinone immunosuppressant.
    Tomkins PT; Cooper KL; Titchmarsh SA; Appleby P; Webber DG
    Int J Immunopharmacol; 1995 May; 17(5):357-66. PubMed ID: 7591359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 15-deoxyspergualin on the induction of cytotoxic T lymphocytes and bone marrow suppression.
    Nishimura K; Tokunaga T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1104-7. PubMed ID: 2784883
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro immunosuppressive effect of deoxymethylspergualin.
    Jiang H; Takahara S; Takano Y; Machida M; Iwasaki A; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Sonoda T
    Transplant Proc; 1990 Aug; 22(4):1633-7. PubMed ID: 2143857
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation.
    Bierer BE; Schreiber SL; Burakoff SJ
    Eur J Immunol; 1991 Feb; 21(2):439-45. PubMed ID: 1705513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new immunosuppressive agent, FK506, inhibits the expression of alloantigen-activated suppressor cells as well as the induction of alloreactivity.
    Yoshimura N; Matsui S; Hamashima T; Lee CJ; Oka T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1045-7. PubMed ID: 2468202
    [No Abstract]   [Full Text] [Related]  

  • 31. FK-506, a potent novel immunosuppressive agent, binds to a cytosolic protein which is distinct from the cyclosporin A-binding protein, cyclophilin.
    Siekierka JJ; Staruch MJ; Hung SH; Sigal NH
    J Immunol; 1989 Sep; 143(5):1580-3. PubMed ID: 2474605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 15-Deoxyspergualin, a novel immunosuppressive drug: studies of the mechanism of action.
    Tepper MA; Nadler S; Mazzucco C; Singh C; Kelley SL
    Ann N Y Acad Sci; 1993 Jun; 685():136-47. PubMed ID: 8363218
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.
    Bunjes D; Hardt C; Röllinghoff M; Wagner H
    Eur J Immunol; 1981 Aug; 11(8):657-61. PubMed ID: 6456149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of FK 506 and cyclosporine on T-cell activation: integrin-mediated adhesion of T cells, proliferation, and maturation of cytotoxic T cells.
    Eiras G; Shimizu Y; van Seventer GA; Duquesnoy RJ; Zeevi A
    Transplant Proc; 1991 Feb; 23(1 Pt 2):936-9. PubMed ID: 1703357
    [No Abstract]   [Full Text] [Related]  

  • 35. Caerulomycin A suppresses immunity by inhibiting T cell activity.
    Singla AK; Gurram RK; Chauhan A; Khatri N; Vohra RM; Jolly RS; Agrewala JN
    PLoS One; 2014; 9(10):e107051. PubMed ID: 25286329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of interleukin 2 on the immunosuppressive action of cyclosporine.
    Hess AD
    Transplantation; 1985 Jan; 39(1):62-8. PubMed ID: 3155579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. II. Inhibition of the production of IL-2 and gamma-IFN, but not B cell-stimulating factor 2.
    Yoshimura N; Matsui S; Hamashima T; Oka T
    Transplantation; 1989 Feb; 47(2):356-9. PubMed ID: 2465593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective suppression by prodigiosin of the mitogenic response of murine splenocytes.
    Nakamura A; Nagai K; Ando K; Tamura G
    J Antibiot (Tokyo); 1986 Aug; 39(8):1155-9. PubMed ID: 2944863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of allograft responses by combining alloantigen-specific i.v. presensitization with suboptimal doses of FK 506 or rapamycin.
    Iwata H; Nagano T; Toyo-oka K; Hirose H; Hamaoka T; Fujiwara H
    Transplant Proc; 1994 Apr; 26(2):851-4. PubMed ID: 7513476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.